Randomized controlled trial of screening for hepatocellular carcinoma
Bo‐heng Zhang,
Bing-hui Yang,
Zhao-You Tang
|
10 |
2004 |
10
2004
|
Cancer active targeting by nanoparticles: a comprehensive review of literature
R. Bazak,
Mohamad T Houri,
Samar El Achy,
Serag Kamel,
T. Refaat
|
9 |
2015 |
9
2015
|
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
8 auth.
R. Nishiwaki‐Matsushima,
T. Ohta,
S. Nishiwaki,
M. Suganuma,
K. Kohyama,
T. Ishikawa,
...
W. Carmichael,
H. Fujiki
|
9 |
2005 |
9
2005
|
The Wnt signaling pathway and its role in tumor development
B. Lustig,
J. Behrens
|
9 |
2003 |
9
2003
|
Radiation-induced fibrosis: mechanisms and implications for therapy
Jeffrey Straub,
J. New,
C. D. Hamilton,
C. Lominska,
Y. Shnayder,
S. Thomas
|
8 |
2015 |
8
2015
|
Cyclooxygenase-2: a novel target for cancer chemotherapy?
W. Dempke,
C. Rie,
A. Grothey,
H. Schmoll
|
8 |
2001 |
8
2001
|
A decade’s studies on metastasis of hepatocellular carcinoma
19 auth.
Zhao-You Tang,
S. Ye,
Yin‐kun Liu,
L. Qin,
Hui-Chuan Sun,
Q. Ye,
Lu Wang,
Jian Zhou,
S. Qiu,
Yan Li,
...
Xue-Ning Ji,
Hu Liu,
Jinglin Xia,
Zhi-quan Wu,
Jia Fan,
Zeng-chen Ma,
Xin-da Zhou,
Zhi-ying Lin,
Kang-da Liu
|
8 |
2004 |
8
2004
|
Giant cell tumor of bone: treatment and outcome of 214 cases
8 auth.
M. Balke,
L. Schremper,
C. Gebert,
H. Ahrens,
A. Streitbuerger,
G. Koehler,
...
J. Hardes,
G. Gosheger
|
8 |
2008 |
8
2008
|
Inhibition of protein phosphatases by microcystis and nodularin associated with hepatotoxicity
7 auth.
S. Yoshizawa,
R. Matsushima,
M. Watanabe,
K. Harada,
A. Ichihara,
W. Carmichael,
...
H. Fujiki
|
8 |
2005 |
8
2005
|
Hereditary cancer: Two hits revisited
A. Knudson
|
8 |
2005 |
8
2005
|
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
K. Sun,
Shuling Chen,
Jianbo Xu,
Guanghua Li,
Yulong He
|
8 |
2014 |
8
2014
|
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
8 auth.
C. Kosmas,
M. Kallistratos,
P. Kopterides,
J. Syrios,
H. Skopelitis,
N. Mylonakis,
...
A. Karabelis,
N. Tsavaris
|
8 |
2007 |
8
2007
|
Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer
16 auth.
Chien‐Ying Liu,
Yu-Min Wang,
Chihuei Wang,
P. Feng,
How-Wen Ko,
Yun-hen Liu,
Yi-cheng Wu,
Y. Chu,
F. Chung,
C. Kuo,
...
Kang-Yun Lee,
Shu-Min Lin,
Horng-Chyuan Lin,
Chun-Hua Wang,
Chih-Teng Yu,
H. Kuo
|
8 |
2009 |
8
2009
|
Characteristics of triple-negative breast cancer
Tim C. de Ruijter,
J. Veeck,
Joep P J de Hoon,
M. van Engeland,
V. Tjan-Heijnen
|
8 |
2010 |
8
2010
|
The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma
Liangliang Xu,
Ming Zhang,
Xiaobo Zheng,
Peng-sheng Yi,
Chuan Lan,
Mingqing Xu
|
8 |
2016 |
8
2016
|
Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression
11 auth.
Lei Pan,
W. Liang,
Min Fu,
Zhenhua Huang,
Xia Li,
Wen Zhang,
...
Peng Zhang,
Hui Qian,
Pengtao Jiang,
Wenrong Xu,
Xu Zhang
|
8 |
2017 |
8
2017
|
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
10 auth.
B. Ricciuti,
C. Genova,
A. De Giglio,
M. Bassanelli,
M. D. Dal Bello,
G. Metro,
...
M. Brambilla,
S. Baglivo,
F. Grossi,
R. Chiari
|
8 |
2018 |
8
2018
|
